Ozempic Briefing for CPG Brands - the 6 Seeds Sustenance
How are weightloss drugs impacting CPG products?
Novo Nordisk, makers of Ozempic and Wegovy is seeing growth of up to 27% in 2024 driven by soaring demand. Ozempic itself saw a 52% sales increase in 2024 while the obesity drug segment containing Wegovy grew by a staggering 154%.
As the use of weight loss medications like Ozempic becomes more prevalent, CPG companies are already stepping up to meet the …
Keep reading with a 7-day free trial
Subscribe to Seeds of Transformation to keep reading this post and get 7 days of free access to the full post archives.